| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Samantha J Broyd, Hendrika H van Hell, Camilla Beale, Murat Yücel, Nadia Solowi. Acute and Chronic Effects of Cannabinoids on Human Cognition-A Systematic Review. Biological psychiatry. vol 79. issue 7. 2016-10-28. PMID:26858214. |
we systematically review the empirical research published in the past decade (from january 2004 to february 2015) on acute and chronic effects of cannabis and cannabinoids and on persistence or recovery after abstinence. |
2016-10-28 |
2023-08-13 |
human |
| Mahmoud A ElSohly, Zlatko Mehmedic, Susan Foster, Chandrani Gon, Suman Chandra, James C Churc. Changes in Cannabis Potency Over the Last 2 Decades (1995-2014): Analysis of Current Data in the United States. Biological psychiatry. vol 79. issue 7. 2016-10-28. PMID:26903403. |
this report examines the concentration of cannabinoids in illicit cannabis products seized by the u.s. drug enforcement administration over the last 2 decades, with particular emphasis on Δ(9)-tetrahydrocannabinol and cannabidiol. |
2016-10-28 |
2023-08-13 |
Not clear |
| Mohini Ranganathan, Patrick D Skosnik, Deepak Cyril D'Souz. Marijuana and Madness: Associations Between Cannabinoids and Psychosis. Biological psychiatry. vol 79. issue 7. 2016-10-28. PMID:26970361. |
marijuana and madness: associations between cannabinoids and psychosis. |
2016-10-28 |
2023-08-13 |
Not clear |
| Mohamed Sherif, Rajiv Radhakrishnan, Deepak Cyril D'Souza, Mohini Ranganatha. Human Laboratory Studies on Cannabinoids and Psychosis. Biological psychiatry. vol 79. issue 7. 2016-10-28. PMID:26970363. |
furthermore, laboratory studies have failed to demonstrate any "beneficial" effects of cannabinoid agonists in individuals with schizophrenia-challenging the cannabis self-medication hypothesis. |
2016-10-28 |
2023-08-13 |
human |
| James S Brodie, Vincenzo Di Marzo, Geoffrey W Gu. Polypharmacology Shakes Hands with Complex Aetiopathology. Trends in pharmacological sciences. vol 36. issue 12. 2016-10-24. PMID:26434643. |
indeed, two combined cannabis extracts were approved as a single medicine (sativex(®)), while pure cannabidiol, a multitarget cannabinoid, is emerging as a treatment for paediatric drug-resistant epilepsy. |
2016-10-24 |
2023-08-13 |
Not clear |
| Samuel T Wilkinson, Stephanie Yarnell, Rajiv Radhakrishnan, Samuel A Ball, Deepak Cyril D'Souz. Marijuana Legalization: Impact on Physicians and Public Health. Annual review of medicine. vol 67. 2016-10-12. PMID:26515984. |
the evidence for the legitimate medical use of marijuana or cannabinoids is limited to a few indications, notably hiv/aids cachexia, nausea/vomiting related to chemotherapy, neuropathic pain, and spasticity in multiple sclerosis. |
2016-10-12 |
2023-08-13 |
Not clear |
| Serkan Ozturk, Yeter Erol Ozturk, Oya Yeter, Buket Alpertung. Application of a validated LC-MS/MS method for JWH-073 and its metabolites in blood and urine in real forensic cases. Forensic science international. vol 257. 2016-10-05. PMID:26360591. |
synthetic cannabinoids, which were synthesized to improve the therapeutic effects of cannabis, have become a major issue when they are abused. |
2016-10-05 |
2023-08-13 |
Not clear |
| Stephanie Hanisch, Alexander Paulke, Stefan W Toenne. Investigation of a recently detected THCCOOH isomer: Post mortem findings and comparison with Δ(8)-THCCOOH. Forensic science international. vol 257. 2016-10-05. PMID:26409163. |
an isomer of the non-psychoactive cannabinoid Δ(9)-thccooh was recently detected in blood from cannabis users. |
2016-10-05 |
2023-08-13 |
Not clear |
| Daniel Brancheau, Jessica Blanco, Gunjan Gholkar, Brijesh Patel, Christian Machad. Cannabis induced asystole. Journal of electrocardiology. vol 49. issue 1. 2016-10-05. PMID:26520167. |
marijuana and other cannabinoids produce a multitude of effects on the human body that may result in these motor vehicle accidents. |
2016-10-05 |
2023-08-13 |
human |
| Benedikt Fischer, Sharan Kuganesan, Andrea Gallassi, Renato Malcher-Lopes, Wim van den Brink, Evan Woo. Addressing the stimulant treatment gap: A call to investigate the therapeutic benefits potential of cannabinoids for crack-cocaine use. The International journal on drug policy. vol 26. issue 12. 2016-09-28. PMID:26500166. |
distinct potential therapeutic benefits for crack-cocaine use and common related adverse symptoms may come specifically from cannabidiol (cbd) - one of the numerous cannabinoid components found in cannabis - with its demonstrated anxiolytic, anti-psychotic, anti-convulsant effects and potential benefits for sleep and appetite problems. |
2016-09-28 |
2023-08-13 |
Not clear |
| Dan P Covey, Jennifer M Wenzel, Joseph F Chee. Cannabinoid modulation of drug reward and the implications of marijuana legalization. Brain research. vol 1628. issue Pt A. 2016-09-27. PMID:25463025. |
cannabinoid modulation of drug reward and the implications of marijuana legalization. |
2016-09-27 |
2023-08-13 |
Not clear |
| Dan P Covey, Jennifer M Wenzel, Joseph F Chee. Cannabinoid modulation of drug reward and the implications of marijuana legalization. Brain research. vol 1628. issue Pt A. 2016-09-27. PMID:25463025. |
the cannabinoid type 1 (cb1) receptor mediates marijuana's psychoactive and reinforcing properties. |
2016-09-27 |
2023-08-13 |
Not clear |
| Fernanda F Peres, Raquel Levin, Valéria Almeida, Antonio W Zuardi, Jaime E Hallak, José A Crippa, Vanessa C Abili. Cannabidiol, among Other Cannabinoid Drugs, Modulates Prepulse Inhibition of Startle in the SHR Animal Model: Implications for Schizophrenia Pharmacotherapy. Frontiers in pharmacology. vol 7. 2016-09-26. PMID:27667973. |
cannabidiol, among other cannabinoid drugs, modulates prepulse inhibition of startle in the shr animal model: implications for schizophrenia pharmacotherapy. |
2016-09-26 |
2023-08-13 |
rat |
| Marco Mul. Investigational new drugs for focal epilepsy. Expert opinion on investigational drugs. vol 25. issue 1. 2016-09-20. PMID:26535466. |
interestingly, despite the structural analogies with tetrahydrocannabinol, the anticonvulsant activity of cannabidiol is not mediated by an interaction with cannabinoid receptors. |
2016-09-20 |
2023-08-13 |
Not clear |
| Xinmei Yang, Takashi Matsui, Takahiro Mori, Futoshi Taura, Hiroshi Noguchi, Ikuro Abe, Hiroyuki Morit. Expression, purification and crystallization of a plant polyketide cyclase from Cannabis sativa. Acta crystallographica. Section F, Structural biology communications. vol 71. issue Pt 12. 2016-09-20. PMID:26625288. |
olivetolic acid cyclase (oac) from cannabis sativa l. is the only known plant polyketide cyclase that catalyzes the c2-c7 intramolecular aldol cyclization of linear pentyl tetra-β-ketide-coa to generate olivetolic acid in the biosynthesis of cannabinoids. |
2016-09-20 |
2023-08-13 |
Not clear |
| Atheer Zgair, Jonathan Cm Wong, Jong Bong Lee, Jatin Mistry, Olena Sivak, Kishor M Wasan, Ivo M Hennig, David A Barrett, Cris S Constantinescu, Peter M Fischer, Pavel Gershkovic. Dietary fats and pharmaceutical lipid excipients increase systemic exposure to orally administered cannabis and cannabis-based medicines. American journal of translational research. vol 8. issue 8. 2016-09-20. PMID:27648135. |
therefore, the aim of this study is to elucidate the effect of oral co-administration of lipids on the exposure to two main active cannabinoids, Δ(9)-tetrahydrocannabinol (thc) and cannabidiol (cbd). |
2016-09-20 |
2023-08-13 |
human |
| Atheer Zgair, Jonathan Cm Wong, Jong Bong Lee, Jatin Mistry, Olena Sivak, Kishor M Wasan, Ivo M Hennig, David A Barrett, Cris S Constantinescu, Peter M Fischer, Pavel Gershkovic. Dietary fats and pharmaceutical lipid excipients increase systemic exposure to orally administered cannabis and cannabis-based medicines. American journal of translational research. vol 8. issue 8. 2016-09-20. PMID:27648135. |
the increase in patient exposure to cannabinoids is of high clinical importance as it could affect the therapeutic effect, but also toxicity, of orally administered cannabis or cannabis-based medicines. |
2016-09-20 |
2023-08-13 |
human |
| Parisa Hasanein, Masumeh Ghafari-Vahe. Fatty acid amide hydrolase inhibitor URB597 prevented tolerance and cognitive deficits induced by chronic morphine administration in rats. Behavioural pharmacology. vol 27. issue 1. 2016-09-19. PMID:26274041. |
inhibitors of the endocannabinoid metabolic enzyme fatty acid amide hydrolase exert therapeutic effects, but might also be associated with some of the adverse effects of cannabis. |
2016-09-19 |
2023-08-13 |
rat |
| Barth L Wilsey, Reena Deutsch, Emil Samara, Thomas D Marcotte, Allan J Barnes, Marilyn A Huestis, Danny L. A preliminary evaluation of the relationship of cannabinoid blood concentrations with the analgesic response to vaporized cannabis. Journal of pain research. vol 9. 2016-09-13. PMID:27621666. |
a preliminary evaluation of the relationship of cannabinoid blood concentrations with the analgesic response to vaporized cannabis. |
2016-09-13 |
2023-08-13 |
human |
| H Valerie Curran, Tom P Freeman, Claire Mokrysz, David A Lewis, Celia J A Morgan, Loren H Parson. Keep off the grass? Cannabis, cognition and addiction. Nature reviews. Neuroscience. vol 17. issue 5. 2016-09-12. PMID:27052382. |
quantifying the relative adverse and beneficial effects of cannabis and its constituent cannabinoids should therefore be prioritized. |
2016-09-12 |
2023-08-13 |
Not clear |